TMDX
TransMedics Group, Inc.
Medical Devices · Healthcare · United States
67.12
close · 2026-10-29
value
18
cheaper than peers18
quality
85
stronger fundamentals85
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 4.49× | 37 |
| forward P/E | 29.78× | 32 |
| price to sales | 4.59× | 29 |
| EV to EBITDA | 28.57× | 15 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 36.3% | 97 |
| operating margin | 12.5% | 81 |
| revenue growth | 20.7% | 77 |
| debt to equity | 167.5% | 19 |
4 of 4 measures available
Facts
| market cap | $2B |
| free cash flow | $44.5M |
| employees | 898 |
| first trade | 2019-05-02 |
| next earnings | 2026-11-05 |
| fundamentals updated | 2026-08-10 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 | 2021 |
| diluted eps | 4.87 | 1.01 | -0.77 | -1.23 | not reported |
| free cash flow | $133.6M | -$80.9M | -$192.1M | -$57.7M | not reported |
| net income | $190.3M | $35.5M | -$25.0M | -$36.2M | not reported |
| revenue | $605.5M | $441.5M | $241.6M | $93.5M | not reported |
| unusual items | not reported | not reported | $300,000 | -$1.9M | $0 |